Adiponectin
Meta Analysis
| Type | median CV estimate | lower CI limit | higher CI limit | Date Updated | Tools |
|---|---|---|---|---|---|
| Between-subject | 51.2 | 35.0 | 90.9 | 2019-10-20 21:11:45 UTC | |
References
No meta analysis Reference included in meta calculation Reference not included in meta calculation| Link | Estimate of CVi | Estimate of CVg | Gender | State of Well Being | Matrix |
|---|---|---|---|---|---|
| Biovariabiity of plasma adiponectin, Shand B, Elder P, Scott R Frampton C and Willis J, 2006, Clin Chem Lab Med, 44, 1264-8 | 18.8 | 51.2 | Mixed | Healthy (excl pregnant) | Plasma |
| Biovariabiity of plasma adiponectin, Shand B, Elder P, Scott R Frampton C and Willis J, 2006, Clin Chem Lab Med, 44, 1264-8 | 12.2 | 38.6 | Mixed | Non-healthy (excl pregnant) | Plasma |
| Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk, Belobrajdic DP, Priebe IK, Forbes B, Flyvbjerg A, Chen JW, Cosgrove LJ, Frystyk J and Saunders IW, 2008, Growth Hormone and IGF Res, 18, 198-204 | 1.4 | 4.35 | Mixed | Healthy (excl pregnant) | Serum |
| Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests, Aziz N, Detels R, Quint JJ, Gjertson D, Ryner T, Butch AW, 2019, BMC Immunol, 20(33), | 15.9 | 48.1 | Mixed | Healthy (excl pregnant) | Serum |